Paper39487558
Analysis of the causal relationship between immune cells and rheumatoid arthritis from the perspective of genetic variation: a bidirectional two-sample Mendelian randomization study.
Cheng F and 5 others. Adv Rheumatol, 2024. Cited by 3 papers, by iCite.
Cite this record
ConductScience Library. Analysis of the causal relationship between immune cells and rheumatoid arthritis from the perspective of genetic variation: a bidirectional two-sample Mendelian randomization study. Papers, record 39487558. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39487558
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Analysis of the causal relationship between immune cells and rheumatoid arthritis from the perspective of genetic variation: a bidirectional two-sample Mendelian randomization study.
- PubMed
Topics7
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Arthritis, Rheumatoid | Major topic |
| Mendelian Randomization Analysis | Major topic |
| Polymorphism, Single Nucleotide | Major topic |
| Humans | |
| Phenotype | |
| Genetic Variation | |
| Genetic Predisposition to Disease |
Source PubMed
Grants2
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| Grant No.2024ZL519 | Zhejiang Traditional Medicine and Technology Program, China | PubMed | ||
| Grant No. 2024KY1380 | Medical Scientific Research Foundation of Zhejiang Province, China | PubMed |
Source PubMed
References50
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 28527048 | Interpreting findings from Mendelian randomization using the MR-Egger method. | Eur J Epidemiol | 2017 | https://conductscience.org/library/papers/28527048 | PubMed |
| 2 | 12689998 | 'Mendelian randomization': can genetic epidemiology contribute to understanding environmental determinants of disease? | Int J Epidemiol | 2003 | https://conductscience.org/library/papers/12689998 | PubMed |
| 3 | 35705856 | Mechanisms of joint destruction in rheumatoid arthritis - immune cell-fibroblast-bone interactions. | Nat Rev Rheumatol | 2022 | https://conductscience.org/library/papers/35705856 | PubMed |
| 4 | 34404786 | Single-cell sequencing of immune cells from anticitrullinated peptide antibody positive and negative rheumatoid arthritis. | Nat Commun | 2021 | https://conductscience.org/library/papers/34404786 | PubMed |
| 5 | 31690319 | Novel immune checkpoint targets: moving beyond PD-1 and CTLA-4. | Mol Cancer | 2019 | https://conductscience.org/library/papers/31690319 | PubMed |
| 6 | 36194479 | NLRC4-mediated activation of CD1c+ DC contributes to perpetuation of synovitis in rheumatoid arthritis. | JCI Insight | 2022 | https://conductscience.org/library/papers/36194479 | PubMed |
| 7 | 31745335 | Interferon target-gene expression and epigenomic signatures in health and disease. | Nat Immunol | 2019 | https://conductscience.org/library/papers/31745335 | PubMed |
| 8 | 32508847 | Th9 Cell Differentiation and Its Dual Effects in Tumor Development. | Front Immunol | 2020 | https://conductscience.org/library/papers/32508847 | PubMed |
| 9 | 34331874 | Cross-tissue single-cell landscape of human monocytes and macrophages in health and disease. | Immunity | 2021 | https://conductscience.org/library/papers/34331874 | PubMed |
| 10 | 34598926 | Loss of balance between protective and pro-inflammatory synovial tissue T-cell polyfunctionality predates clinical onset of rheumatoid arthritis. | Ann Rheum Dis | 2022 | https://conductscience.org/library/papers/34598926 | PubMed |
| 11 | 36797236 | Signaling pathways in rheumatoid arthritis: implications for targeted therapy. | Signal Transduct Target Ther | 2023 | https://conductscience.org/library/papers/36797236 | PubMed |
| 12 | 24114802 | Mendelian randomization analysis with multiple genetic variants using summarized data. | Genet Epidemiol | 2013 | https://conductscience.org/library/papers/24114802 | PubMed |
| 13 | 34048945 | Cancer Cell-Specific Major Histocompatibility Complex II Expression as a Determinant of the Immune Infiltrate Organization and Function in the NSCLC Tumor Microenvironment. | J Thorac Oncol | 2021 | https://conductscience.org/library/papers/34048945 | PubMed |
| 14 | 38789047 | Comment on ''Associations between rheumatoid arthritis and skin cancer: A bidirectional two-sample Mendelian randomization study''. | J Am Acad Dermatol | 2024 | https://conductscience.org/library/papers/38789047 | PubMed |
| 15 | 31501349 | Immunogenicity of a rheumatoid arthritis protective sequence when acquired through microchimerism. | Proc Natl Acad Sci U S A | 2019 | https://conductscience.org/library/papers/31501349 | PubMed |
| 16 | 37052755 | Repurposing antidiabetic drugs for rheumatoid arthritis: results from a two-sample Mendelian randomization study. | Eur J Epidemiol | 2023 | https://conductscience.org/library/papers/37052755 | PubMed |
| 17 | 27098907 | Family history of rheumatoid arthritis: an old concept with new developments. | Nat Rev Rheumatol | 2016 | https://conductscience.org/library/papers/27098907 | PubMed |
| 18 | 27061298 | Consistent Estimation in Mendelian Randomization with Some Invalid Instruments Using a Weighted Median Estimator. | Genet Epidemiol | 2016 | https://conductscience.org/library/papers/27061298 | PubMed |
| 19 | 35415310 | Dimethylamino group modified polydopamine nanoparticles with positive charges to scavenge cell-free DNA for rheumatoid arthritis therapy. | Bioact Mater | 2022 | https://conductscience.org/library/papers/35415310 | PubMed |
| 20 | 20453842 | Genome-wide association study meta-analysis identifies seven new rheumatoid arthritis risk loci. | Nat Genet | 2010 | https://conductscience.org/library/papers/20453842 | PubMed |
Cited by1
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 3 citations.
| PMID | Title | Journal | Year | In Papers |
|---|---|---|---|---|
| 40746530 | Exosome circ-CBLB promotes M1 macrophage polarization in rheumatoid arthritis through the TLR3/TRAF3 signaling axis. | Front Immunol | 2025 | https://conductscience.org/library/papers/40746530 |
Source PubMed
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/39487558
GET https://conductscience.org/api/papers/v1/39487558/references?page=2